Spectrum Pharmaceuticals (SPPI +4.6%) finishes the day higher after saying late yesterday that...


Spectrum Pharmaceuticals (SPPI +4.6%) finishes the day higher after saying late yesterday that safety findings from its Phase 2 trial of belinostat showed an acceptable profile in patients with relapsed T-cell lymphoma.

Comments (5)
  • Jonha's Pop
    , contributor
    Comments (67) | Send Message
     
    Now that seems a more reasonable response, to GOOD news.
    29 Jan 2013, 04:31 PM Reply Like
  • TwistTie
    , contributor
    Comments (2429) | Send Message
     
    That's what I was thinking.

     

    It took 24 hours for this to sink in?

     

    Or is more news coming?
    29 Jan 2013, 04:43 PM Reply Like
  • pagreen1966
    , contributor
    Comments (661) | Send Message
     
    I wish this stock would really take off as we do need a short squeeze.
    29 Jan 2013, 06:10 PM Reply Like
  • beachie
    , contributor
    Comments (37) | Send Message
     
    must be more news
    29 Jan 2013, 08:21 PM Reply Like
  • craig thomas
    , contributor
    Comments (42) | Send Message
     
    Maybe triggered by this article talking about buyout .. http://on-msn.com/14tBmKk
    29 Jan 2013, 09:11 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs